Cheerland Biotechnology

Founded in 2021 in Shenzhen, China, Cheerland Biotechnology (CLB) is a leading biologics contract development and manufacturing organization (CDMO). Led by an international team with extensive experiences in the biotech industry, CLB provides global biotech and biopharma clients with world-class facilities featuring the first 15kL bioreactors in China, robust process design, digital quality systems, and compliance with cGMP standards and global regulatory requirements. Currently CLB is building state-of-the-art CDMO plants in Shenzhen and Shanghai, with a total capacity of ~700 kL by 2024. Cheerland Biotechnology, the World’s Local CDMO. Goal: Build the most comprehensive biologics CDMO for clinical and commercial supply to the global market. Mission: Change the world for the better, by providing affordable medicine to patients worldwide.